The PE Ratio as of November 2025 (TTM) for Revance Therapeutics, Inc. (RVNC) is -1.09

According to Revance Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.09. This represents a change of -61.09% compared to the average of -2.81 of the last 4 quarters.

Revance Therapeutics, Inc. (RVNC) Historical PE Ratio (quarterly & annually)

How has RVNC PE Ratio performed in the past?

The mean historical PE Ratio of Revance Therapeutics, Inc. over the last ten years is -5.73. The current -1.09 PE Ratio has changed 1.81% with respect to the historical average. Over the past ten years (40 quarters), RVNC's PE Ratio was at its highest in in the September 2023 quarter at -1.76. The PE Ratio was at its lowest in in the June 2015 quarter at -11.22.

Revance Therapeutics, Inc. (RVNC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Revance Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Revance Therapeutics, Inc. (RVNC) Average PE Ratio

How has RVNC PE Ratio performed in the past?

The current PE Ratio of Revance Therapeutics, Inc. (RVNC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Revance Therapeutics, Inc. (RVNC) PE Ratio vs. Peers

How is RVNC’s PE Ratio compared to its peers?

Revance Therapeutics, Inc.’s PE Ratio is greater than Orchard Therapeutics plc (-27.11), greater than G1 Therapeutics, Inc. (-7.72), greater than Vigil Neuroscience, Inc. (-4.16), less than Checkpoint Therapeutics, Inc. (-0.05), greater than Y-mAbs Therapeutics, Inc. (-17.56), greater than Climb Bio, Inc. (-2.50), greater than iTeos Therapeutics, Inc. (-2.18), greater than Claritev Corporation (-1.78), less than Big Cypress Acquisition Corp. (2.99), greater than SomaLogic, Inc. (-3.54),

Build a custom stock screener for Revance Therapeutics, Inc. (RVNC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Revance Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Revance Therapeutics, Inc. (RVNC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Revance Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.